drugset / Trial / NCT02723461

Continuous Oxytocin Infusion Versus Pulsatile Intravenous Oxytocin for Augmentation of First Stage of Labor

NCT02723461

Phase 4 Unknown 120 enrolled Ain Shams Maternity Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

Comparing continuous intravenous oxytocin infusion with pulsatile administration of intravenous oxytocin for augmentation of the first stage of labor.

Timeline

Start
2016-03
Primary completion
2017-01
Completion
2017-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxytocin Peptide 0.002 iu Intravenous

Indications

No indication recorded.